What This Means for Future Treatment
Landmark Research Links GLP-1 Injections to Cancer Risk Reduction
Recent studies highlighted in national media suggest that GLP-1 medications, such as Wegovy, Mounjaro and Ozempic, may reduce cancer risk by up to 50% in obese individuals. The research builds on evidence that chronic obesity is linked to several types of cancer and that sustained weight loss can significantly improve long-term health outcomes.
The findings come amid growing demand for GLP-1 receptor agonists, medications originally developed for type 2 diabetes but now increasingly prescribed for weight management due to their powerful appetite-suppressing effects.
Toni Russo: “We’re Looking at a Public Health Game-Changer”
Toni Russo, a leading bariatric nurse and obesity specialist, says these findings underscore the importance of making medically supervised weight loss options accessible.
“If these figures hold true, we’re not just managing obesity, we’re potentially intervening in cancer prevention. That changes the conversation entirely,” says Toni.
Having worked with patients for over 20 years, Toni has seen firsthand how sustained weight loss improves overall health, reduces comorbidities, and now, possibly cuts cancer risk.
She emphasises that weight loss injections should only be taken under the supervision of a regulated medical provider, a message echoed by UK health authorities.
Not a One-Size-Fits-All Fix
While the data is promising, Toni warns against seeing these treatments as a silver bullet:
“Weight loss injections aren’t a miracle cure. They work best when part of a clinically supervised plan that includes nutrition, psychological support, and physical activity.”
She also notes the importance of patient screening, especially as GLP-1 drugs can interact with existing conditions and medications.
How Harley Street Obesity Clinic Can Help
At Harley Street Obesity Clinic, Toni Russo is part of a multidisciplinary, surgeon-led team that offers:
- Remote consultations
- Home delivery of licensed medications (like Mounjaro and Wegovy)
- Ongoing clinical support
- Full regulatory compliance
Patients can begin their treatment from home with no clinic visits required, ensuring both safety and convenience.
As research continues to show the far-reaching benefits of weight loss injections, access to expert care becomes more crucial than ever. With leaders like Toni Russo at the forefront, Harley Street Obesity Clinic is setting a new standard in safe, personalised obesity treatment.